EMA
UTILITIESEmera Incorporated
$52.27-0.33 (-0.63%)PRE
Live · NYSE · May 9, Close
AI Insight
What's Moving EMA Today?
No stock-specific AI insight has been generated for EMA yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$40.15$53.51
$52.27
Fundamentals
Market Cap$16.0B
P/E Ratio21.1
EPS$2.48
Dividend Yield0.06%
Dividend / Share$2.91
ROE0.1%
Profit Margin0.1%
Debt / Equity—
Trading
Volume290K
Avg Volume (10D)—
Shares Outstanding305.8M
EMA News
24 articles- Emera Inc (EMA) Q1 2026 Earnings Call Highlights: Strong Growth and Strategic Investments ...Yahoo Finance·May 9, 2026
- Emera Files May Form 6-K with Q1 2026 Results and Earnings Coverage DataTipRanks·May 8, 2026
- Emera’s Q1 2026 Results: Net Income Reaches $212 Million, Customer Base Expands to 2.5 MillionGeneOnline·May 8, 2026
- Emera Reports 2026 First Quarter Financial ResultsYahoo Finance·May 8, 2026
- Emera Incorporated Announces Results of Series J First Preferred Share ConversionYahoo Finance·May 5, 2026
- Emera Energy Leadership Shift Puts Investor Focus On Risk And Capital AllocationYahoo Finance·May 3, 2026
- Emera Inc. Announces Leadership Transition at Emera EnergyYahoo Finance·Apr 30, 2026
- RBC Changes Estimates for Select Canadian Energy Infrastructure CompaniesYahoo Finance·Apr 27, 2026
- Emera Incorporated Announces Dividend Rates for Series J and Series K First Preferred SharesYahoo Finance·Apr 15, 2026
- Emera Declares Quarterly DividendsYahoo Finance·Apr 13, 2026
- Is It Too Late To Consider Emera (TSX:EMA) After Its Strong Multi Year Rally?Yahoo Finance·Apr 10, 2026
- Emera Incorporated Announces Conversion Privilege of Cumulative Minimum Rate Reset First Preferred Shares, Series JYahoo Finance·Apr 9, 2026
- Emera Teleconference on May 8 to Discuss Q1 2026 ResultsYahoo Finance·Apr 7, 2026
- Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic NeuritisGlobeNewswire Inc.·Mar 31, 2026
- Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic NeuritisGlobeNewswire Inc.·Mar 31, 2026
- Emera Incorporated Announces the Closing of the Offering of US$750 Million Aggregate Principal Amount of Senior NotesYahoo Finance·Mar 27, 2026
- Emera Incorporated announces the closing of the offering of US$750 million Aggregate Principal Amount of Fixed-to-Fixed Reset Rate Junior Subordinated NotesYahoo Finance·Mar 23, 2026
- How The Emera (TSX:EMA) Investment Narrative Is Shifting With Mixed Analyst ViewsYahoo Finance·Feb 25, 2026
- Emera Maintained at Outperform at BMO After Q4 Results; Price Target Raised to C$74.00Yahoo Finance·Feb 24, 2026
- Emera Q4 Earnings Call HighlightsMarketbeat·Feb 24, 2026
- Emera Inc (EMA) Q4 2025 Earnings Call Highlights: Record Net Income and Strategic Investments ...Yahoo Finance·Feb 23, 2026
- Emera Reports 2025 Fourth Quarter Financial and Annual Financial Results, Extends Growth TargetYahoo Finance·Feb 23, 2026
- Nova Scotia Power Announces CEO TransitionYahoo Finance·Feb 10, 2026
- With 51% ownership, Emera Incorporated (TSE:EMA) boasts of strong institutional backingYahoo Finance·Feb 5, 2026
All 24 articles loaded
Price Data
Open$52.48
Previous Close$52.60
Day High$52.75
Day Low$52.18
52 Week High$53.51
52 Week Low$40.15
52-Week Range
$40.15$53.51
$52.27
Fundamentals
Market Cap$16.0B
P/E Ratio21.1
EPS$2.48
Dividend Yield0.06%
Dividend / Share$2.91
ROE0.1%
Profit Margin0.1%
Debt / Equity—
Trading
Volume290K
Avg Volume (10D)—
Shares Outstanding305.8M
About Emera Incorporated
Emera Incorporated, an energy and services company, invests in generation, transmission, and distribution of electricity in the United States, Canada, Barbados, and the Bahamas. The company is headquartered in Halifax, Canada.
7.8K employees
UTILITIESUTILITIES - REGULATED ELECTRIC
Company Details
Security TypeStock
ExchangeNYSE
CurrencyUSD
Round Lot—
SICUTILITIES - REGULATED ELECTRIC
CIK—
Composite FIGI—
Share Class FIGI—